tiprankstipranks
GenSight Biologics SA (FR:SIGHT)
:SIGHT
France Market

GenSight Biologics SA (SIGHT) Financial Statements

Compare
2 Followers

GenSight Biologics SA Financial Overview

GenSight Biologics SA's market cap is currently €30.42M. The company's EPS TTM is €-0.146; its P/E ratio is ―; GenSight Biologics SA is scheduled to report earnings on March 21, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue€ 1.27M€ 2.58M€ 5.28M€ 4.39M€ 700.00K
Gross Profit€ 3.00M€ 2.58M€ 5.28M€ 4.39M€ 700.00K
Operating Income€ -29.70M€ -27.84M€ -28.13M€ -24.93M€ -30.30M
EBITDA€ -21.73M€ -26.44M€ -26.83M€ -34.13M€ -29.31M
Net Income€ -26.22M€ -27.62M€ -28.62M€ -34.02M€ -30.71M
Balance Sheet
Cash & Short-Term Investments€ 2.13M€ 10.61M€ 44.29M€ 37.94M€ 19.25M
Total Assets€ 9.13M€ 25.94M€ 56.65M€ 47.36M€ 32.48M
Total Debt€ 18.43M€ 12.65M€ 12.57M€ 14.45M€ 7.95M
Net Debt€ 16.29M€ 2.04M€ -31.72M€ -23.49M€ -11.30M
Total Liabilities€ 39.83M€ 41.22M€ 40.66M€ 35.69M€ 20.74M
Stockholders' Equity€ -30.67M€ -15.28M€ 15.99M€ 11.67M€ 11.75M
Cash Flow
Free Cash Flow€ -24.67M€ -34.01M€ -17.17M€ -15.05M€ -28.19M
Operating Cash Flow€ -24.66M€ -33.75M€ -17.14M€ -15.04M€ -28.11M
Investing Cash Flow€ 209.00K€ 172.00K€ -16.00K€ -376.00K€ -102.00K
Financing Cash Flow€ 15.86M€ 95.00K€ 23.74M€ 33.86M€ 21.25M
Currency in EUR

GenSight Biologics SA Earnings and Revenue History

GenSight Biologics SA Debt to Assets

GenSight Biologics SA Cash Flow

GenSight Biologics SA Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis